Stay updated on U3-1402 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the U3-1402 in NSCLC Clinical Trial page.

Latest updates to the U3-1402 in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed study design and inclusion criteria for a clinical trial on HER3-DXd in NSCLC, while adding new identifiers and collaborators related to the study.SummaryDifference42%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe page has updated its recruiting status to indicate that it is now actively recruiting, and the revision number has changed from v2.14.2 to v2.14.3. Additionally, the dates for recruiting have shifted from November 2024 to March 2025.SummaryDifference0.8%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
Stay in the know with updates to U3-1402 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the U3-1402 in NSCLC Clinical Trial page.